Compensation Plans (Tables)

12 Months Ended

Dec. 31, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of weighted average grant date fair values and related assumptions for grants made

The following table summarizes the weighted average grant date fair values and related assumptions for grants made during the year ended December 31, 2016:

	December 31, 2016
Grant-date fair value	$	45.88
Expected volatility	76.3		%
Expected term (in years)	5
Risk-free rate	1.2		%

Schedule of stock options activity

The following table sets forth certain information regarding our stock options as of December 31, 2016:

		Weighted Average
	Options	Exercise Price		Remaining Term	Aggregate Intrinsic Value
Outstanding at January 1, 2016	—	$	—
Granted	282,000	$	74.21
Exercised	—	$	—
Outstanding at December 31, 2016	282,000	$	74.21
Vested and expected to vest at December 31, 2016	282,000	$	74.21	6.7	$	12,705,250
Exercisable at December 31, 2016	—	$	—	—	$	—

Schedule of restricted stock activity

The following table presents our restricted stock activity as of December 31, 2016:

	Restricted Stock Awards		Weighted-Average Grant Date Fair Value
Unvested at January 1, 2016	—		$	—
Granted	410,165		$	71.26
Vested	(25,000	)	$	63.11
Forfeited	—		$	—
Unvested at December 31, 2016	385,165		$	71.79

Schedule of aggregate compensation under non-equity award plans reflected on the balance sheet

Accrued compensation under non-equity award plans is reflected in the accompanying consolidated balance sheets as detailed in the following schedule:

	2016		2015
	(In thousands)
Current liabilities:
Accrued liabilities and other	$	1,087	$	1,251
Non-current liabilities:
Accrued compensation under non-equity award plans	4,655		16,254
Total accrued compensation under non-equity award plans	$	5,742	$	17,505